PRISES Biotechnology on teadus- ja arendustegevusel põhinev tootja, kes tegeleb in vitro diagnostikareaktiivide (IVD) ja meditsiiniseadmete arendamise, tootmise ja kauplemisega, mis on heaks kiitnud NMPA (CFDA) IVD-toodete tootmiseks ja kauplemiseks ning tegutseb ISO 13485 kvaliteedisüsteemi alusel. toodetel on CE-märgis.
Established 11 years ago, the company has become a well-established and dynamic business through continuous efforts and improvements.
Class 100,000 clean workshop 1000 square metres, Class 10,000 microbiological test room 500 square metres, fully equipped quality control room, R&D laboratory, laboratory, etc.
The company has a research and development team of 35 people who drive the technology and support the development of new products for the company.
We provide the highest level of service to our customers, whether it's answering questions, solving problems or providing valuable advice, we deal with it promptly.
The company has a large team of professionals responsible for managing, coordinating and controlling the operations of the various functions.